₹ 2,668.30
85.40 (3.31%)
M
Mankind Pharma
₹ 2,668.30
Mankind Pharma EPS Summary (consolidated)
The latest quarterly EPS of Mankind Pharma as of Q2 Sep 2026 stands at ₹17.23. This is a 25.22% growth quarter on quarter and 39.06% growth same quarter last year. The forecasted EPS for Q2 Sep 2026 was ₹15.97. It beat the estimate by ₹1.26. For the FY2026 the EPS of Mankind Pharma stands at ₹46.35. This is a 5.95% fall compared with FY2025.
Mankind Pharma EPS
EPS by Peers

S
Sun Pharmaceutical

D
Divis Laboratories

T
Torrent Pharmaceuticals

L
Laurus Labs

Z
Zydus Life Science
*Based on consolidated figures.

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App

